Metagenomi Therapeutics annual operating margin
2022
2023
2024
2025
Metagenomi Therapeutics Operating Margin Growth & History (MGX)
Metagenomi Therapeutics's operating margin was −380.85% for fiscal 2025.
View full Metagenomi Therapeutics company overviewMetagenomi Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −380.85% | −210.85 pp |
| 2024 | 2024-12-31 | −170.00% | +5.38 pp |
| 2023 | 2023-12-31 | −175.38% | +84.16 pp |
| 2022 | 2022-12-31 | −259.53% | — |
Metagenomi Therapeutics quarterly operating margin
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | −1,970.11% | −1296.01 pp |
| Q4 2025 | 2025-12-31 | −623.04% | −408.53 pp |
| Q3 2025 | 2025-09-30 | −263.76% | −69.36 pp |
| Q2 2025 | 2025-06-30 | −246.53% | −162.25 pp |
| Q1 2025 | 2025-03-31 | −674.10% | −413.93 pp |
| Q4 2024 | 2024-12-31 | −214.51% | −51.63 pp |
| Q3 2024 | 2024-09-30 | −194.40% | −13.25 pp |
| Q2 2024 | 2024-06-30 | −84.28% | +74.16 pp |
| Q1 2024 | 2024-03-31 | −260.17% | −52.96 pp |
| Q4 2023 | 2023-12-31 | −162.88% | — |
| Q3 2023 | 2023-09-30 | −181.15% | — |
| Q2 2023 | 2023-06-30 | −158.45% | — |
| Q1 2023 | 2023-03-31 | −207.21% | — |
Metagenomi Therapeutics operating margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Metagenomi Therapeutics's operating margin decreased from −259.53% to −380.85%, a change of −121.32 percentage points. The latest reported quarter, Q1 2026, shows −1,970.11%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Metagenomi Therapeutics source filings ↗